BOM:524518 (India)
Â
Shs Dematerialised
₹
64.65
(+2.8%)
Jun 5
Current and historical daily PE Ratio for Krebs Biochemicals & Industries Ltd (
) from 2000 to Jun 06 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Krebs Biochemicals & Industries stock (BOM:524518) PE ratio as of Jun 06 2024 is 0.
More Details
Krebs Biochemicals & Industries Ltd (BOM:524518) PE Ratio (TTM) Chart
Krebs Biochemicals & Industries Ltd (BOM:524518) PE Ratio (TTM) Historical Data
View and export this data going back to 2000. Start your Free Trial
Total 1233
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Krebs Biochemicals & Industries PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-06 | At Loss | 2024-03-26 | At Loss |
| 2024-06-04 | At Loss | 2024-03-22 | At Loss |
| 2024-06-03 | At Loss | 2024-03-21 | At Loss |
| 2024-05-31 | At Loss | 2024-03-20 | At Loss |
| 2024-05-29 | At Loss | 2024-03-19 | At Loss |
| 2024-05-28 | At Loss | 2024-03-18 | At Loss |
| 2024-05-27 | At Loss | 2024-03-14 | At Loss |
| 2024-05-24 | At Loss | 2024-03-13 | At Loss |
| 2024-05-23 | At Loss | 2024-03-12 | At Loss |
| 2024-05-22 | At Loss | 2024-03-11 | At Loss |
| 2024-05-21 | At Loss | 2024-03-07 | At Loss |
| 2024-05-17 | At Loss | 2024-03-06 | At Loss |
| 2024-05-16 | At Loss | 2024-03-05 | At Loss |
| 2024-05-15 | At Loss | 2024-03-04 | At Loss |
| 2024-05-14 | At Loss | 2024-03-01 | At Loss |
| 2024-05-13 | At Loss | 2024-02-29 | At Loss |
| 2024-05-10 | At Loss | 2024-02-28 | At Loss |
| 2024-05-09 | At Loss | 2024-02-27 | At Loss |
| 2024-05-08 | At Loss | 2024-02-26 | At Loss |
| 2024-05-07 | At Loss | 2024-02-23 | At Loss |
| 2024-05-06 | At Loss | 2024-02-22 | At Loss |
| 2024-05-03 | At Loss | 2024-02-21 | At Loss |
| 2024-05-02 | At Loss | 2024-02-20 | At Loss |
| 2024-04-30 | At Loss | 2024-02-19 | At Loss |
| 2024-04-29 | At Loss | 2024-02-16 | At Loss |
| 2024-04-26 | At Loss | 2024-02-15 | At Loss |
| 2024-04-25 | At Loss | 2024-02-14 | At Loss |
| 2024-04-24 | At Loss | 2024-02-13 | At Loss |
| 2024-04-23 | At Loss | 2024-02-12 | At Loss |
| 2024-04-22 | At Loss | 2024-02-09 | At Loss |
| 2024-04-19 | At Loss | 2024-02-08 | At Loss |
| 2024-04-18 | At Loss | 2024-02-07 | At Loss |
| 2024-04-16 | At Loss | 2024-02-06 | At Loss |
| 2024-04-15 | At Loss | 2024-02-05 | At Loss |
| 2024-04-12 | At Loss | 2024-02-02 | At Loss |
| 2024-04-10 | At Loss | 2024-02-01 | At Loss |
| 2024-04-09 | At Loss | 2024-01-31 | At Loss |
| 2024-04-08 | At Loss | 2024-01-30 | At Loss |
| 2024-04-05 | At Loss | 2024-01-29 | At Loss |
| 2024-04-04 | At Loss | 2024-01-25 | At Loss |
| 2024-04-03 | At Loss | 2024-01-24 | At Loss |
| 2024-04-02 | At Loss | 2024-01-23 | At Loss |
| 2024-04-01 | At Loss | 2024-01-19 | At Loss |
| 2024-03-28 | At Loss | 2024-01-18 | At Loss |
| 2024-03-27 | At Loss | 2024-01-17 | At Loss |
Krebs Biochemicals & Industries Ltd (BOM:524518) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Krebs Biochemicals & Industries Ltd
ISIN : INE268B01013
Share Class Description:
BOM:524518: Shs DematerialisedCompare
Compare
Traded in other countries / regions
KREBSBIO.India IPO Date
2000-05-17Description
Krebs Biochemicals & Industries Ltd is a biochemical company in India. It is engaged in the business of manufacture of active pharmaceutical ingredients. It has two manufacturing plants in Andhra Pradesh, India - one in Nellore and one in Vizag both Units are equipped for chemical synthesis, fermentation, and enzymatic technologies providing Krebs with production capacity.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers